Conavi Medical Statistics

Total Valuation

Conavi Medical has a market cap or net worth of CAD 28.40 million. The enterprise value is 47.71 million.

Market Cap	28.40M
Enterprise Value	47.71M

Important Dates

The next estimated earnings date is Friday, August 29, 2025.

Earnings Date	Aug 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Conavi Medical has 76.75 million shares outstanding. The number of shares has increased by 292.49% in one year.

Current Share Class	76.75M
Shares Outstanding	76.75M
Shares Change (YoY)	+292.49%
Shares Change (QoQ)	+4.96%
Owned by Insiders (%)	0.55%
Owned by Institutions (%)	0.00%
Float	42.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.97
PB Ratio	-1.05
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.21
EV / Sales	4.98
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.11

Financial Position

The company has a current ratio of 0.23

Current Ratio	0.23
Quick Ratio	0.14
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.90
Interest Coverage	-1.31

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	650.48%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	0.43
200-Day Moving Average	n/a
Relative Strength Index (RSI)	40.74
Average Volume (20 Days)	45,669

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Conavi Medical had revenue of CAD 9.57 million and -39.28 million in losses. Loss per share was -1.63.

Revenue	9.57M
Gross Profit	7.21M
Operating Income	-20.26M
Pretax Income	-39.28M
Net Income	-39.28M
EBITDA	-19.77M
EBIT	-20.26M
Loss Per Share	-1.63

Full Income Statement

Balance Sheet

The company has 1.04 million in cash and 20.35 million in debt, giving a net cash position of -19.31 million or -0.25 per share.

Cash & Cash Equivalents	1.04M
Total Debt	20.35M
Net Cash	-19.31M
Net Cash Per Share	-0.25
Equity (Book Value)	-26.97M
Book Value Per Share	-0.61
Working Capital	-7.61M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -22.30 million and capital expenditures -323,000, giving a free cash flow of -22.62 million.

Operating Cash Flow	-22.30M
Capital Expenditures	-323,000
Free Cash Flow	-22.62M
FCF Per Share	-0.29

Full Cash Flow Statement

Margins

Gross Margin	75.30%
Operating Margin	-211.57%
Pretax Margin	-410.24%
Profit Margin	n/a
EBITDA Margin	-206.52%
EBIT Margin	-211.57%
FCF Margin	n/a

Dividends & Yields

Conavi Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-292.49%
Shareholder Yield	n/a
Earnings Yield	-138.31%
FCF Yield	-79.66%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 16, 2024. It was a reverse split with a ratio of 0.04.

Last Split Date	Oct 16, 2024
Split Type	Reverse
Split Ratio	0.04

Scores

Conavi Medical has an Altman Z-Score of -41.3 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-41.3
Piotroski F-Score	3